Radiographic damage in rheumatoid arthritis correlates with functional disability but not direct medical costs
- PMID: 11708412
Radiographic damage in rheumatoid arthritis correlates with functional disability but not direct medical costs
Abstract
Objective: Few longitudinal data exist on the relationship between radiographic damage and self-reported functional disability and direct medical costs in rheumatoid arthritis (RA). We assessed these relationships.
Methods: One hundred thirty patients with RA (at time of the first available radiograph, mean age 56.6 yrs, 16.9% male, mean disease duration 16.8 yrs) were followed for up to 13.4 years. Semiannually, they reported on functional disability (0 = no difficulty, 3 = unable to do), global severity (0 = very well, 100 = very poor), pain (0 = no pain, 3 = severe pain), and health services utilization through completion of the Stanford Health Assessment Questionnaire (HAQ). Concurrent hand radiographs were scored for erosions and joint space narrowing using the Genant method and a single score summing both erosions and joint space narrowing for both hands was calculated (0 = no damage, 200 = maximum damage). The univariate association of functional disability, global severity, pain, or direct medical costs with concurrent radiographic damage was assessed through Spearman correlations and hierarchical regression models. The hierarchical models permit exploitation of the between-patient and within-patient variation present in our longitudinal data.
Results: At the time of the first available radiograph, mean (SD) levels of functional disability, global severity, and pain were 1.3 (0.7), 39.4 (21.0), and 1.1 (0.7), respectively. At entry into the study, the average radiograph score was 49.7 and upon leaving the study it was 66.9. Patients were followed an average of 6.7 years, with radiograph scores increasing at an average rate of 2.5 units/yr. The Spearman correlation [95% confidence interval (CI)] between average per-patient radiograph score and average per-patient HAQ disability index, average per-patient global severity, average per-patient pain score, and average per-patient direct medical costs was, respectively, 0.42 (0.26, 0.55), 0.23 (0.06, 0.39), 0.20 (0.03, 0.36), and 0.06 (-0.11, 0.23). The mean slope (95% CI) for disability on radiograph score was 0.0186 (0.0132, 0.0226), for severity on radiographs 0.1889 (0.1295, 0.2498), and for pain on radiographs 0.0057 (0.0027, 0.0084). As an example, over 10 years, a 25 unit (i.e., 50%) increase in radiograph scores would, on average, be associated with a 0.46 unit (i.e., 35%) increase in disability, a 4.72 unit (12%) increase in global severity score, and a 0.14 unit (13%) increase in pain, all expressed on the HAQ scales. There was little association between radiograph score and direct medical costs.
Conclusion: A clinically meaningful association exists between radiographic damage and self-reported functional disability, suggesting that interventions that slow radiographic progression may improve the patient's health status. Such a relationship was not observed between radiographic damage and direct medical costs.
Similar articles
-
[A multicenter cross-sectional study on the health related quality of life of patients with rheumatoid arthritis using a revised Japanese version of the arthritis impact measurement scales version 2 (AIMS 2), focusing on the medical care costs and their associative factors].Ryumachi. 2002 Feb;42(1):23-39. Ryumachi. 2002. PMID: 11925904 Japanese.
-
Predicting the short term direct medical costs incurred by patients with rheumatoid arthritis.J Rheumatol. 1999 May;26(5):1068-75. J Rheumatol. 1999. PMID: 10332970
-
Predictors of the progression of functional disability in patients with ankylosing spondylitis.J Rheumatol. 2002 Jul;29(7):1420-5. J Rheumatol. 2002. PMID: 12136900
-
The HAQ compared with the MDHAQ: "keep it simple, stupid" (KISS), with feasibility and clinical value as primary criteria for patient questionnaires in usual clinical care.Rheum Dis Clin North Am. 2009 Nov;35(4):787-98, ix. doi: 10.1016/j.rdc.2009.10.011. Rheum Dis Clin North Am. 2009. PMID: 19962623 Review.
-
Advantages and limitations of quantitative measures to assess rheumatoid arthritis: joint counts, radiographs, laboratory tests, and patient questionnaires.Bull NYU Hosp Jt Dis. 2006;64(1-2):32-9. Bull NYU Hosp Jt Dis. 2006. PMID: 17121487 Review.
Cited by
-
Infliximab: a pharmacoeconomic review of its use in rheumatoid arthritis.Pharmacoeconomics. 2004;22(2):107-32. doi: 10.2165/00019053-200422020-00004. Pharmacoeconomics. 2004. PMID: 14731052 Review.
-
Etanercept: a pharmacoeconomic review of its use in rheumatoid arthritis.Pharmacoeconomics. 2004;22(16):1071-95. doi: 10.2165/00019053-200422160-00004. Pharmacoeconomics. 2004. PMID: 15524495 Review.
-
Association between baseline radiographic damage and improvement in physical function after treatment of patients with rheumatoid arthritis.Ann Rheum Dis. 2005 Jan;64(1):52-5. doi: 10.1136/ard.2003.017160. Epub 2004 Jul 29. Ann Rheum Dis. 2005. PMID: 15286005 Free PMC article. Clinical Trial.
-
Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis.Arthritis Rheum. 2009 Sep 15;61(9):1248-56. doi: 10.1002/art.24789. Arthritis Rheum. 2009. PMID: 19714593 Free PMC article.
-
Health Assessment Questionnaire disability progression in early rheumatoid arthritis: systematic review and analysis of two inception cohorts.Semin Arthritis Rheum. 2014 Oct;44(2):131-44. doi: 10.1016/j.semarthrit.2014.05.003. Epub 2014 May 9. Semin Arthritis Rheum. 2014. PMID: 24925692 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials